ARS Pharmaceuticals, Inc. SPRY
3.95 USD +0.38 (+10.64%)
At closeNov 11, 2026, 7:52 PM EST
3.92 -0.03 -0.77%
After hours · Nov 11, 7:52 PM ET
3.57 Day range 4.13
2.44 52-week range 13.15
- YTD
- -66.09%
- 1 year
- -54.96%
SPRY revenue history
Revenue is income from the company’s ordinary business activities.
84,278,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 84,278,000 | -4,871,000 | -5.46% |
| FY 2024 | 2024-12-31 | 89,149,000 | 89,119,000 | 297063.33% |
| FY 2023 | 2023-12-31 | 30,000 | -1,286,000 | -97.72% |
| FY 2022 | 2022-12-31 | 1,316,000 | -4,190,000 | -76.10% |
| FY 2021 | 2021-12-31 | 5,506,000 | 5,506,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:33.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.